|
|
Previous Article | Table of Contents | Next Article 
A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias
J Morrissey, DC Tkachuk, A Milatovich, U Francke, M Link and ML Cleary
Department of Pathology, Stanford University School of Medicine, CA
94305-5324.
Translocations involving chromosome band 11q23 in acute leukemias have
recently been shown to involve the HRX gene that codes for a protein with
significant similarity to Drosophila trithorax. HRX gene alterations are
consistently observed in t(4;11) (q21;q23)-carrying leukemias and cell
lines by Southern blot analyses and are accompanied by HRX transcripts of
anomalous size on Northern blots. HRX-homologous cDNAs were isolated from a
library prepared from t(4;11)-carrying acute leukemia cells. cDNAs
representative of transcription products from the derivative 11 chromosome
were shown to contain HRX sequences fused to sequences derived from
chromosome band 4q21. Fragments of the latter were used to clone and
analyze cDNAs for wild-type 4q21 transcripts that predicted a 140-Kd basic
protein (named FEL) that is rich in prolines, serines, and charged amino
acids. FEL contains guanosine triphosphate-binding and nuclear localization
consensus sequences and uses one of two possible 5' exons encoding the
first 12 or 5 amino acids. After t(4;11) translocations, 913 C-terminal
amino acids of FEL are fused in frame to the N-terminal portion of HRX
containing its minor groove DNA binding motifs. These features are similar
to predicted t(11;19) fusion proteins, suggesting that HRX consistently
contributes a novel DNA-binding motif to at least two different chimeric
proteins in acute leukemias.
Volume 81,
Issue 5,
pp. 1124-1131,
03/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Bensaid, M. Melko, E. G. Bechara, L. Davidovic, A. Berretta, M. V. Catania, J. Gecz, E. Lalli, and B. Bardoni
FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure
Nucleic Acids Res.,
March 1, 2009;
37(4):
1269 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Urano, M. Endoh, T. Wada, Y. Morikawa, M. Itoh, Y. Kataoka, T. Taki, H. Akazawa, H. Nakajima, I. Komuro, et al.
Infertility with Defective Spermiogenesis in Mice Lacking AF5q31, the Target of Chromosomal Translocation in Human Infant Leukemia
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6834 - 6845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cimino, L. Elia, M. Mancini, L. Annino, B. Anaclerico, P. Fazi, A. Vitale, G. Specchia, F. Di Raimondo, A. Recchia, et al.
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome
Blood,
September 15, 2003;
102(6):
2014 - 2020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Saso, T. Ito, S. Natori, and K. Sekimizu
Identification of a Novel Tissue-Specific Transcriptional Activator FESTA as a Protein That Interacts with the Transcription Elongation Factor S-II
J. Biochem.,
April 1, 2003;
133(4):
493 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Collins, A. Appert, L. Ariza-McNaughton, R. Pannell, Y. Yamada, and T. H. Rabbitts
Mouse Af9 Is a Controller of Embryo Patterning, Like Mll, Whose Human Homologue Fuses with AF9 after Chromosomal Translocation in Leukemia
Mol. Cell. Biol.,
October 15, 2002;
22(20):
7313 - 7324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Bertrand, C. Vogtenhuber, N. Shah, and T. W. LeBien
Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein
Blood,
December 1, 2001;
98(12):
3398 - 3405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Isnard, N. Core, P. Naquet, and M. Djabali
Altered lymphoid development in mice deficient for the mAF4 proto-oncogene
Blood,
July 15, 2000;
96(2):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cimino, L. Elia, M. C. Rapanotti, T. Sprovieri, M. Mancini, A. Cuneo, C. Mecucci, G. Fioritoni, M. Carotenuto, E. Morra, et al.
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia
Blood,
January 1, 2000;
95(1):
96 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Felix and B. J. Lange
Leukemia in Infants
Oncologist,
June 1, 1999;
4(3):
225 - 240.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. Rubnitz, B. M. Camitta, H. Mahmoud, S. C. Raimondi, A. J. Carroll, M. J. Borowitz, J. J. Shuster, M. P. Link, D. J. Pullen, J. R. Downing, et al.
Childhood Acute Lymphoblastic Leukemia With the MLL-ENL Fusion and t(11;19)(q23;p13.3) Translocation
J. Clin. Oncol.,
January 1, 1999;
17(1):
191 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, J. L. Frestedt, and J. H. Kersey
AF4 Encodes a Ubiquitous Protein That in Both Native and MLL-AF4 Fusion Types Localizes to Subnuclear Compartments
Blood,
November 15, 1998;
92(10):
3841 - 3847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schnittger, B. Wormann, W. Hiddemann, and F. Griesinger
Partial Tandem Duplications of the MLL Gene Are Detectable in Peripheral Blood and Bone Marrow of Nearly All Healthy Donors
Blood,
September 1, 1998;
92(5):
1728 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Uckun, K. Herman-Hatten, M.-L. Crotty, M. G. Sensel, H. N. Sather, L. Tuel-Ahlgren, M. B. Sarquis, B. Bostrom, J. B. Nachman, P. G. Steinherz, et al.
Clinical Significance of MLL-AF4 Fusion Transcript Expression in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23) Chromosomal Translocation
Blood,
August 1, 1998;
92(3):
810 - 821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Kersey
Fifty Years of Studies of the Biology and Therapy of Childhood Leukemia
Blood,
December 1, 1997;
90(11):
4243 - 4251.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shilatifard, D. Haque, R. C. Conaway, and J. W. Conaway
Structure and Function of RNA Polymerase II Elongation Factor ELL. IDENTIFICATION OF TWO OVERLAPPING ELL FUNCTIONAL DOMAINS THAT GOVERN ITS INTERACTION WITH POLYMERASE AND THE TERNARY ELONGATION COMPLEX
J. Biol. Chem.,
August 29, 1997;
272(35):
22355 - 22363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Hilden, F. O. Smith, J. L. Frestedt, R. McGlennen, W. B. Howells, P. H.B. Sorensen, D. C. Arthur, W. G. Woods, J. Buckley, I. D. Bernstein, et al.
MLL Gene Rearrangement, Cytogenetic 11q23 Abnormalities, and Expression of the NG2 Molecule in Infant Acute Myeloid Leukemia
Blood,
May 15, 1997;
89(10):
3801 - 3805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Frazer, Y. Ueda, Y. Zhu, V. R. Gifford, M. R. Garofalo, N. Mohandas, C. H. Martin, M. J. Palazzolo, J.-F. Cheng, and E. M. Rubin
Computational and Biological Analysis of 680 kb of DNA Sequence from the Human 5q31 Cytokine Gene Cluster Region
Genome Res.,
May 1, 1997;
7(5):
495 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Schichman, E. Canaani, and C. M. Croce
Self-fusion of the ALL 1 Gene: A New Genetic Mechanism for Acute Leukemia
JAMA,
February 15, 1995;
273(7):
571 - 576.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Van Aelst, M.A. White, and M.H. Wigler
Ras Partners
Cold Spring Harb Symp Quant Biol,
January 1, 1994;
59(0):
181 - 186.
[Abstract]
[PDF]
|
 |
|
|
|